NFE2L2 and cancer: ROS endorse transcription factor like nuclear factor erythroid 2-related factor 2 (Nrf-2) that promote survival of cancer cells under high levels of ROS by endorsing secondary antioxidant enzymes and this chemical modification additionally increases the capacity of drug resistance [26].